About CRO in Russia - Clinical Excellence Group (CEG)

Clinical Trials in Russia

Clinical Excellence Group

CEG

Nickolay Kryuchkov

Drugs Registration

International Clinical Trials

post marketing surveillance

registration drugs

international clinical trials

marketing observational research

patient support programs

dietary supplement registration

cosmetic certification

CEG contacts

contact form




About Us

Clinical Excellence Group is a contract research and development organization providing full range of services in the area of Clinical Trials, Non-Interventional Studies, Non-Clinical Studies, registration of Drugs, Medical devices, Food Supplements and Cosmetics in Russia / the Eurasian Economic Union.
Since 2011.

Leave Your Contact Details in the form below. We'll contact you within a day.

Completed Projects

17
Companies are working with us
23
Registered Drugs
46
Registered Food Supplements
19
Completed Clinical Trials
4
Non-Interventional Studies
40+
Non-Clinical Studies
14
R&D Strategies for original drugs and medical devices
63
Participants passed CEG Training Courses and Workshops
Ethical Code
Based in Russia and working with global companies we bring best practices to research that are based on ethical behavior, quality assurance and first class service.

CEG team is consisted of professionals experienced in working with international companies and educated in the reputable Russian and international universities.

We are proud that a young and ambitious company can make a change in research and positively impact patients' lives.

We ground our work by doing the right thing and assuring each step is made in the right direction.

Therefore, we created and follow our
CEG Ethical Code.

✔ We abide the local laws and global guidelines.

Our reputation is the key and each step matters. CEG high compliance standards ensure that all routine practices have a solid legal background and leadership team is involved in general guidance and detailed instructions.

✔ We strictly follow the principle: Do not harm. We carefully gather info about all side-effects and treatment outcomes.
Trials are conducted to help patients live longer and obtain better quality of life - this goal is always kept in our mind. We believe that only ethical professionals can do so. CEG was established for the long-term and such principle talks by itself. Jointly with trial sponsor we carefully analyze benefits and risks for each product. CEG professionals proactively communicate their findings.

✔ Our communication with physicians, patients and clients is open and clea.
Without honesty, courage and support the result would be unattainable. We make sure every procedure is carefully communicated and all stakeholders are on the same page. Being trained all around the world we know by experience how important is to listen to each other.

✔ We always have informed consent form for the patients and ensure private information protection.
Of course, there is legal regulation that we abide to. But not less is important is trust. Trust is fundamental when it comes to health. Our partners in medical hospitals know by experience that they can trust us and patients' materials will be kept confidential.

✔ Quality assurance is in place at all stages of research and data analysis.
To make the data reliable we naturally invest in modern technology. Additionally, we are well educated in standard operating procedures. What matters most is that we apply our brains in excellent analysis once the trial moves to the final stage.

✔ Our employees are the unique resources and great personalities. Therefore, we constantly invest in growth by conducting regular trainings.
By the end of the day, we can only sell what are good at and such is our expertise. We value each other as people and professionals. We are a good team and come to work because we want and like doing it.

We want the EAEU a part of international environment and follow the highest ethical and quality standards. We can make it real by doing our everyday work.
Team
We are Russian professionals trained in the reputable international universities. Our successful experience with reputable multinational and local companies makes us confident we understand our clients' needs and act effectively. We carefully monitor regulatory environment and conduct internal trainings.

We are:
✔ High-performing and mobile team;
✔ With excellent communication skills;
✔ Ready to assist our clients in case of challenge;
✔ We know and enjoy what we do.

Six of our specialists have more than 7 years of work experience in pharmaceutical companies and international Contract Research Organizations, four specialists have more than 12 years of experience.

Our team includes 6 unique medical writers and biostatisticians - there are only few such professionals in Russia and bordering countries.

In 2012-2017, CEG successfully passed 5 audits by international Sponsors.

Every year our company's staff takes an assessment of knowledge of Standard Operating Procedures and the legislation of Russia and the Eurasian Economic Union.
Business Processes
Our work is guided by standards established on the market of healthcare products registration and biomedical studies.

This goes for development and implementation of 38 Standard Operating Procedures (SOPs) and Policies, 100+ Standard Forms, Logs and Tables that regulate organization, monitoring and audit of Clinical Trials, selection of investigation sites, logistics, drug circulation, pharmacovigilance and study participants' safety, conduct of nonclinical studies, adverse event handling and many other activities.

This is an additional guarantee of your projects' success.

Nickolay Kryuchkov
CEO
Medical doctor (M.D., Stavropol State Medical Academy), Ph.D. (K.M.N., Immunology and Allergy, NRC Institute of Immunology FMBA Russia), Master of Public Health (M.P.H., Hebrew University of Jerusalem, Israel), Master of Business Administration (M.B.A., International Business School MIRBIS).

Since 2011, Nickolay is a founder and CEO of Clinical Excellence Group LLC.

He has 12 years of experience in pharmaceutical industry (as senior manager, head of department and C.E.O., 70+ completed projects of drug registration and clinical studies), 21 years of experience in biomedical research, 6 junior researcher awards.

Nickolay is a founder and C.E.O. of eHealth First Company, developing an IT-platform for Personalized Health and Longevity Management.

He is an editor and co-author of Russia's first multimedia Course on Biostatistics, which was recommended by Organizational and methodological union of Russian High schools (Universities) on medical and pharmaceutical education for medical under- and postgraduates (2006), editor and co-author of Evidence-based Guideline for People living with HIV/AIDS, healthcare providers and public health professionals (2009).

He was a member of the Advisory Board of the Quality of Life (Health) Project of the State Duma of the Federal Assembly of the Russian Federation (2010-2011), а member of the Advisory Board on the Reform and Modernization of the Healthcare System and Demographics Policy of the Civic Chamber of the Russian Federation (2012).

Nickolay is an author of 65 publications in Russian and International peer-reviewed journals and Conference Abstract Books, expert in healthcare for Russian media (TVC, 1TV, MIR, MIR 24, TV 360, OTR).

His Biography is included in Marquis Who's Who in the World, 2012-2016 (29th-33rd editions) and 2000 Outstanding intellectuals of the 21st century, 2012-2015 (7th-10th editions).

LinkedIn See
Facebook See
eHealth First See
CV (pdf) See
MIR TV: SR9009, innovative drugs (in Rus) See
MIR TV: Ineffective drugs on the market (in Rus) See
OTR: Homeopathic medicines vs. EBM (in Rus) See
TVC: Availability of drugs and pharmaceutical industry (in Rus) See
EBM Guideline on HIV / AIDS (2009, pdf, in Rus) See

Contact Us

It is easy, convenient and only takes a few minutes.
Please send us Your comments, questions, suggestions, details about Your Company, Your goals, and planned Projects through this Form. Leave your contact information and we will respond within 24 hours.